Evidence map›Paper›PMID 31539656›Full record

ArticleActa biomaterialia2019

Characterizing the impact of 2D and 3D culture conditions on the therapeutic effects of human mesenchymal stem cell secretome on corneal wound healing in vitro and ex vivo.

Kaylene Carter, Hyun Jong Lee, Kyung-Sun Na, Gabriella Maria Fernandes-Cunha, Ignacio Jesus Blanco, Ali Djalilian, David Myung

Open access · bronzeAbstract read
In one paragraph

Article in Acta biomaterialia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 1 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 1 synthesis or guideline pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Cell and Gene Therapy in Equine Ocular Disease.Veterinary ophthalmology · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Kaylene CarterOphthalmology, Byers Eye Institute at Stanford University School of Medicine, Palo Alto, CA, United States.
Hyun Jong LeeOphthalmology, Byers Eye Institute at Stanford University School of Medicine, Palo Alto, CA, United States; Chemical and Biological Engineering, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea.
Kyung-Sun NaOphthalmology, Byers Eye Institute at Stanford University School of Medicine, Palo Alto, CA, United States; Ophthalmology & Visual Science, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Gabriella Maria Fernandes-CunhaOphthalmology, Byers Eye Institute at Stanford University School of Medicine, Palo Alto, CA, United States.
Ignacio Jesus BlancoOphthalmology, Byers Eye Institute at Stanford University School of Medicine, Palo Alto, CA, United States.
Ali DjalilianOphthalmology & Visual Sciences, University of Illinois at Chicago, Illinois, United States.
David MyungOphthalmology, Byers Eye Institute at Stanford University School of Medicine, Palo Alto, CA, United States; Chemical Engineering, Stanford University, Palo Alto, California, United States; VA Palo Alto HealthCare System, Palo Alto, California, United States. Electronic address: djmyung@stanford.edu.
Smith-Kettlewell Eye Research Institute · USGachon University · KRPalo Alto University · USThe Catholic University of Korea Yeouido St. Mary's Hospital · KRUniversity of Illinois Chicago · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCANANY, JAMES JASON · 1985 to 2025
$14.8M
Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Novel Therapies for Ocular Chemical InjuriesR01EY024349 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DJALILIAN, ALI R · 2015 to 2020
$2.1M
Stanford Vision Training ProgramT32EY027816 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2018 to 2026
$2.0M
In Situ Bioconjugation as a Therapeutic Delivery Modality to Enhance Ocular Wound HealingK08EY028176 · NEI · STANFORD UNIVERSITY · PI MYUNG, DAVID · 2017 to 2021
$1.1M
Corneal Reconstruction through an In Situ-Forming Collagen GelI21RX003179 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI MYUNG, DAVID · 2019 to 2021
–
NEI NIH HHS K08 EY028176NEI NIH HHS P30 EY001792NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY024349NEI NIH HHS T32 EY027816RRD VA I21 RX003179
6 · The paper itself

Abstract

The therapeutic effects of secreted factors (secretome) produced by bone marrow-derived human mesenchymal stem cells (MSCs) were evaluated as a function of their growth in 2D culture conditions and on 3D electrospun fiber scaffolds. Electrospun fiber scaffolds composed of polycaprolactone and gelatin were fabricated to provide a 3D microenvironment for MSCs, and their mechanical properties were optimized to be similar to corneal tissue. The secretome produced by the MSCs cultured on 3D fiber matrices versus 2D culture dishes were analyzed using a Luminex immunoassay, and the secretome of MSCs cultured on the 3D versus 2D substrates showed substantial compositional differences. Concentrations of factors such as HGF and ICAM-1 were increased over 5 times in 3D cultures compared to 2D cultures. In vitro proliferation and scratch-based wound healing assays were performed to compare the effects of the secretome on corneal fibroblast cells (CFCs) when delivered synchronously from co-cultured MSCs through a trans-well co-culture system versus asynchronously after harvesting the factors separately and adding them to the media. Cell viability of CFCs was sustained for 6 days when co-cultured with MSCs seeded on the fibers but decreased with time under other conditions. Scratch assays showed 95% closure at 48 h when CFCs were co-cultured with MSCs seeded on fibers, while the control group only exhibited 50% closure at 48 h. Electrospun fibers seeded with MSCs were then applied to a rabbit corneal organ culture system, and MSCs seeded on fibers promoted faster epithelialization and less scarring. Corneas were fixed and stained for alpha smooth muscle actin (α-SMA), and then analyzed by confocal microscopy. Immunostaining showed that expression of α-SMA was lower in corneas treated with MSCs seeded on fibers, suggesting suppression of myofibroblastic transformation. MSCs cultured on electrospun fibers facilitate wound healing in CFCs and on explanted corneas through differential secretome profiles compared to MSCs cultured on 2D substrates. Future work is merited to further understand the nature and basis of these differences and their effects in animal models. STATEMENT OF SIGNIFICANCE: Previous studies have shown that the secretome of bone marrow-derived mesenchymal stem cells (MSC) is promotes corneal wound healing by facilitating improved wound closure rates and reduction of scarring and neovascularization. The present research is significant because it provides evidence for the modulation of the secretome as a function of the MSC culture environment. This leads to differential expression of therapeutic factors secreted, which can impact corneal epithelial and stromal healing after severe injury. In addition, this article shows that co-continuous delivery of the MSC secretome improves cell migration and proliferation over aliquoted delivery, and that MSCs grown on three-dimensional electrospun fiber constructs may provide a favorable microenvironment for cultured MSCs and as a carrier to deliver their secreted factors to the ocular surface.

Indexed as

Wound HealingActinsAnimalsBone Marrow CellsCell DifferentiationCell SurvivalCoculture TechniquesCorneaCorneal InjuriesFibroblastsHepatocyte Growth FactorHumansImaging, Three-DimensionalIntercellular Adhesion Molecule-1In Vitro TechniquesMesenchymal Stem CellsActinsHepatocyte Growth FactorICAM1 protein, humanIntercellular Adhesion Molecule-1Corneal wound healingMesenchymal stem cellsRegenerationRegenerative medicine

Identifiers

PMID31539656
PMCPMC7101245
OpenAlexW2974825403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.